日本薬理学会年会要旨集
Online ISSN : 2435-4953
第93回日本薬理学会年会
セッションID: 93_1-S01-3
会議情報

シンポジウム
新しい抑制性シナプス形成分子InSyn1の同定とその機能障害による神経疾患発症の分子機序
*上江洲 章吉ハイジ エレン小林 芳彦ガオ ユドングブラッドショー タイラーデヴリン パトリックロドリゲス ラモーナタタ プリュショサマソダリング スコット
著者情報
会議録・要旨集 オープンアクセス

詳細
抄録

Human mutations in the dystroglycan complex (DGC) result in not only muscular dystrophy, but also cognitive impairments. However, the molecular architecture critical for the synaptic organization of the DGC in neurons remains elusive. Here we report Inhibitory Synaptic protein 1 (InSyn1) is a critical component of the DGC whose loss alters the composition of the GABAergic synapses, excitatory/inhibitory balance in vitro and in vivo, and cognitive behavior. Association of InSyn1 with DGC subunits is required for InSyn1 synaptic localization. InSyn1 null neurons also show a significant reduction in DGC and GABA receptor distribution as well as abnormal neuronal network activity. Moreover, InSyn1 null mice exhibit elevated neuronal firing patterns in the hippocampus and deficits in fear conditioning memory. Our results support the dysregulation of the DGC at inhibitory synapses as a driver of altered neuronal network activity and specific cognitive tasks via a novel component, InSyn1.

著者関連情報
© 2020 本論文著者
前の記事 次の記事
feedback
Top